블로그
- Phase III Trial Results Suggest a New Standard of Care in Metastatic HER2-Positive Breast Cancer Standard of Care in Metastatic HER2-Positive Breast Cancer In the phase III DESTINY-Breast09 trial, first-line progression by more than 1 year—nearly doubling the time of disease control—over standard treatment
- Autophagy: Drugging the yin and yang of the cell Can biotech companies walk the fine line between boosting and inhibiting autophagy to treat disease without
- Hands Like Houses - Glasshouse (가사 번역) A silver line, a disease on the horizon 은색 선, 지평선 위의 질병 A whistling in the trees, it marches on 나무에서
- Acne: ‘diabetes of the skin’ Acne vulgaris is an inflammatory skin disease which is most often associated with the onset of puberty secretion produced by sebaceous glands in the outer layer of skin); disruption of the cells which line